Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 53,89
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Edité par Kluwer Academic / Plenum Publishers, New York., 1999
ISBN 10 : 0306461072 ISBN 13 : 9780306461071
Langue: anglais
Vendeur : Tiber Books, Cockeysville, MD, Etats-Unis
EUR 43,92
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Very Good. 8vo, hardcover. No dj, as issued. Vg condition. Non-circulating ex-lib copy w/ label inside cover, exterior labels neatly removed (only markings); contents quite bright & clean, binding tight, covers glossy. viii, 271 p., illus. Proceedings of the Fifth Triennial Symposium on New Directions in Antiviral Chemotherapy, held November 13-15, 1997, in San Francisco, CA.
Edité par Kluwer Academic/Plenum Publishers, c1999., New York, 1999
ISBN 10 : 0306461072 ISBN 13 : 9780306461071
Langue: anglais
Vendeur : Research Ink, Takoma Park, MD, Etats-Unis
EUR 21,96
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierHardback. Etat : Very Good. viii + 271 pp. Advances in Experimental Medicine and Biology5. Rubber-stamped on front free endpaper. book.
Vendeur : The Warm Springs Book Company, Fremont, CA, Etats-Unis
Edition originale
EUR 52,66
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Fine. 1st Edition. A fine copy issued without a DJ. Former owner's name on inside of front cover; slight trace of wear to pictorial boards; 1st edition with complete number line; illustrated; 8vo., 440 pages.
Vendeur : Romtrade Corp., STERLING HEIGHTS, MI, Etats-Unis
EUR 125,79
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Vendeur : GoldBooks, Denver, CO, Etats-Unis
EUR 117,73
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : new.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 164,45
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 164,45
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 153,88
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 153,88
Autre deviseQuantité disponible : 15 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Best Price, Torrance, CA, Etats-Unis
EUR 148,32
Autre deviseQuantité disponible : 2 disponible(s)
Ajouter au panierEtat : New. SUPER FAST SHIPPING.
Vendeur : Best Price, Torrance, CA, Etats-Unis
EUR 148,32
Autre deviseQuantité disponible : 2 disponible(s)
Ajouter au panierEtat : New. SUPER FAST SHIPPING.
Edité par Springer US, Springer New York, 2012
ISBN 10 : 1461371503 ISBN 13 : 9781461371502
Langue: anglais
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 164,49
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Edité par Springer US, Springer New York Mär 1999, 1999
ISBN 10 : 0306461072 ISBN 13 : 9780306461071
Langue: anglais
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 160,49
Autre deviseQuantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. Neuware -Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 282 pp. Englisch.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 164,44
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Edité par Springer US, Springer New York, 1999
ISBN 10 : 0306461072 ISBN 13 : 9780306461071
Langue: anglais
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 168,73
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierBuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 179,32
Autre deviseQuantité disponible : 15 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 179,65
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : As New. Unread book in perfect condition.
EUR 190,87
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : Used. pp. 460.
EUR 190,44
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 460 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 183,99
Autre deviseQuantité disponible : 15 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Edité par Springer-Verlag New York Inc., 2012
ISBN 10 : 1461371503 ISBN 13 : 9781461371502
Langue: anglais
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
EUR 195,14
Autre deviseQuantité disponible : 15 disponible(s)
Ajouter au panierEtat : New. Editor(s): Mills, John; Volberding, Paul A.; Corey, Lawrence. Series: Advances in Experimental Medicine and Biology. Num Pages: 271 pages, biography. BIC Classification: MF; MJCJ; MJCM; PSB. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 14. Weight in Grams: 537. . 2012. Softcover reprint of the original 1st ed. 1999. Paperback. . . . .
EUR 194,89
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 460.
Vendeur : Best Price, Torrance, CA, Etats-Unis
EUR 191,80
Autre deviseQuantité disponible : 2 disponible(s)
Ajouter au panierEtat : New. SUPER FAST SHIPPING.
Vendeur : Best Price, Torrance, CA, Etats-Unis
EUR 191,80
Autre deviseQuantité disponible : 2 disponible(s)
Ajouter au panierEtat : New. SUPER FAST SHIPPING.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 203,83
Autre deviseQuantité disponible : 15 disponible(s)
Ajouter au panierEtat : New.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 204,08
Autre deviseQuantité disponible : 15 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 217,49
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
EUR 156,82
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 217,49
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.